Leon Berge has been employed at the Cancer Registry of Norway since 2017 as a PhD student in the etiological group within the department of research, where he among other things studies the significance of prescription drugs in the development of cutaneous melanoma. His research interests include communicable and non-communicable disease epidemiology and public health.
Berge took his Bachelor (BscH) degree in microbiology with a combined Masters (MSci) degree at the University of Glasgow in 2011-2016. This was followed by an additional Masters degree with a focus on quantitative methods in epidemiology in 2016-2017, also at the University of Glasgow, where his thesis was on the prevalence and risk factors associated with viral intestinal disease.
For his PhD thesis, Berge is currently conducting a register- and population-based pharmacoepidemiological project (Prescribed Drugs and Cutaneous Melanoma) to study the associations between prescription cardiovascular, antidepressant and immunosuppressive drugs and the development of cutaneous melanoma in Norway.
Berge LAM, Andreassen BK, Stenehjem JS, Larsen IK, Furu K, Juzeniene A, Roscher I, Heir T, Green A, Veierød MB, Robsahm TE (2019)
Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study
BMJ Open, 9 (2), e025246
DOI 10.1136/bmjopen-2018-025246, PubMed 30787091